Search results
Results from the WOW.Com Content Network
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. [2] Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. [5]
United Therapeutics Corporation is an American publicly traded biotechnology company [2] and public benefit corporation [3] listed on the NASDAQ under the symbol UTHR. [4] [5] It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.
In March 2021, the company announced that it had selected Holly Springs, North Carolina, located near its existing operations in Morrisville, for a $2 billion investment to establish a new large-scale cell culture production site, which is expected to be operational in 2025 and create 725 new jobs by the end of 2028. The company plans to ...
The announcement adds to Eastern North Carolina’s reputation as a pharmaceutical manufacturing hub Johnson & Johnson plans 420-worker plant in Eastern NC, as area gets another biotech boost Skip ...
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides ...
Precision BioSciences' proprietary technology is the ARCUS platform and ARCUS nucleases. [4] [8] ARCUS nucleases are based on a naturally occurring genome editing enzyme, I-CreI, a homing endonuclease that evolved in the algae Chlamydomonas reinhardtii [4] [12] to make highly specific cuts and DNA insertions in cellular DNA. [15]
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.
Wake Forest Biotech Building. Innovation Quarter in Winston-Salem, North Carolina, formerly Wake Forest Innovation Quarter, is an innovation district focused on research, business, and education in biomedical science, information technology, digital media, clinical services, and advanced materials. [1]